Sponsor pipeline

Chen Xiaoping clinical trial pipeline

Get alerts when Chen Xiaoping's trials change

5 active trials 3 recruiting 1 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-11
Trial completed
Enrollment increased: 200 → 251 participants
Completion pushed: 2025-12-31 → 2026-07-30
NCT06248554 Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following…

Active trials by phase

Phase 2
1
Phase 4
3
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06311929 Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma HCC Recruiting 2024-05-07
NCT06311942 Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC. HCC Recruiting 2024-05-07
NCT06311916 Efficacy and Safety of Neoadjuvant Therapy in Patients With Resectable HCC Screened by a… HCC Not Yet Recruiting 2024-03-15
Phase 2
NCT06420440 Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep… HCC Recruiting 2025-05-01
Not applicable
NCT06248528 Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus… Hepatocellular Carcinoma Active, Not Recruiting 2025-07-16

Disease areas by active trials

Liver Cancer (5)

Get alerts when Chen Xiaoping's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free